| Linda A Burger, NP | |
|
246 Granger Rd, Suite 1, Berlin, VT 05602-9516 | |
| (802) 371-5950 | |
| (802) 371-5951 |
| Full Name | Linda A Burger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 246 Granger Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770504516 | NPI | - | NPPES |
| ONP2161 | Medicaid | VT |
| Mailing Address | Practice Location Address |
|---|---|
| Linda A Burger, NP Po Box 547, Central Vermont Medical Center - Finance Dept, Barre, VT 05641-0547 Ph: (802) 371-5950 | Linda A Burger, NP 246 Granger Rd, Suite 1, Berlin, VT 05602-9516 Ph: (802) 371-5950 |
News Archive
Experts are warning that manipulating the upper spine during back treatments could be dangerous.
Neurological scientists at Rush University Medical Center have found that using cinnamon, a common food spice and flavoring material, can reverse the biomechanical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD).
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Anthrax may soon help more people win the fight against bladder cancer, which the Centers for Disease Control and Prevention says strikes about 72,000 Americans each year and kills about 16,000, and is one of the most expensive cancers to treat.
Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that preliminary top-line results of its Phase 3 clinical trial evaluating the safety and efficacy of its treatment for sickle cell anemia and sickle beta-0 thalassemia met both the primary and secondary endpoints of the clinical trial.
› Verified 4 days ago
Ms. Quincy Campbell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Rd, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
Christina Marie Tourangeau, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1311 Barre-montpelier Road, Suite 200, Berlin, VT 05602 Phone: 802-371-4239 Fax: 802-371-4237 | |
David Alexander Segel, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-225-7000 | |
Karen Gibbs, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 142 Woodridge Rd, Berlin, VT 05602 Phone: 802-371-4700 | |
Abbey Lynne Rouleau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Cvmc Palliative Care, 130 Fisher Road 2nd Floor, Berlin, VT 05602 Phone: 802-371-5372 | |
Margaret Jones, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-471-2100 | |
Morgan Lamson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Central Vermont Medical Center, 130 Fisher Road, Berlin, VT 05602 Phone: 802-371-4700 Fax: 802-371-4720 |